Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial.
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of the study is to compare the safety and efficacy of ESWL and visual cystolitholapaxy in management of calcular acute urine retention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Mar 2015
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 30, 2015
CompletedFirst Posted
Study publicly available on registry
November 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedNovember 3, 2015
October 1, 2015
1 year
October 30, 2015
October 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stone free rate
evaluation of stone free rate after the assigned intevention
1 week
Secondary Outcomes (1)
Adverse events after the assigned intervention
1 month
Study Arms (2)
ESWL Group
ACTIVE COMPARATORPatients in this arm will receive ESWL as treatment for acute calcular urinary retention
Endoscopy group
ACTIVE COMPARATORPatients in this arm will receive endoscopic treatment for acute calcular urinary retention
Interventions
Patients in this arm will receive ESWL for treatment of acute calcular urinary retention
Patients in this arm will receive endoscopic treatment of acute calcular urinary retention
Eligibility Criteria
You may qualify if:
- Adult male patients presenting with acute urinary retention due to urethral or urinary bladder stones.
- with a stone size not more than 2 centimeters in greatest diameter.
- No more than 2 stones.
You may not qualify if:
- Bladder cancer.
- Bladder replacement of any type.
- Infravesical obstruction, due to marked benign prostatic hyperplasia, prostate cancer, stricture urethra or external urethral meatal stenosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Urology an Nephrology Center
Al Mansurah, DK, 35516, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ahmed A Shokeir, Prof
Urology and Nephrology Cenetr
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident in Urology, Urology and Nephrology Center, Mansoura University
Study Record Dates
First Submitted
October 30, 2015
First Posted
November 3, 2015
Study Start
March 1, 2015
Primary Completion
March 1, 2016
Study Completion
April 1, 2016
Last Updated
November 3, 2015
Record last verified: 2015-10